Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $3.35 $5.09 Wednesday, 8th May 2024 RLMD stock ended at $3.83. This is 0.262% more than the trading day before Tuesday, 7th May 2024. During the day the stock fluctuated 5.32% from a day low at $3.75 to a day high of $3.95.
90 days $3.35 $7.22
52 weeks $2.36 $7.22

Historical Relmada Therapeutics, Inc. prices

Date Open High Low Close Volume
Jan 22, 2024 $3.44 $3.71 $3.44 $3.61 230 537
Jan 19, 2024 $3.41 $3.47 $3.35 $3.44 86 292
Jan 18, 2024 $3.31 $3.43 $3.26 $3.41 96 365
Jan 17, 2024 $3.20 $3.40 $3.10 $3.30 217 511
Jan 16, 2024 $3.11 $3.27 $3.08 $3.27 145 121
Jan 12, 2024 $3.33 $3.53 $3.08 $3.14 157 405
Jan 11, 2024 $3.34 $3.44 $3.27 $3.31 225 056
Jan 10, 2024 $3.47 $3.63 $3.27 $3.37 299 641
Jan 09, 2024 $3.40 $3.51 $3.31 $3.42 228 537
Jan 08, 2024 $3.34 $3.50 $3.25 $3.44 305 463
Jan 05, 2024 $3.10 $3.45 $2.92 $3.32 637 176
Jan 04, 2024 $4.50 $4.51 $3.06 $3.10 2 773 063
Jan 03, 2024 $4.38 $4.70 $4.16 $4.53 435 162
Jan 02, 2024 $4.24 $4.41 $3.93 $4.37 333 216
Dec 29, 2023 $3.75 $4.33 $3.68 $4.14 291 796
Dec 28, 2023 $4.22 $4.32 $3.63 $3.79 422 854
Dec 27, 2023 $3.28 $4.35 $3.24 $4.22 861 460
Dec 26, 2023 $3.05 $3.30 $3.05 $3.28 496 856
Dec 22, 2023 $3.00 $3.20 $2.90 $3.06 413 152
Dec 21, 2023 $2.49 $2.97 $2.46 $2.95 1 033 091
Dec 20, 2023 $2.46 $2.57 $2.44 $2.45 302 617
Dec 19, 2023 $2.53 $2.56 $2.45 $2.48 825 915
Dec 18, 2023 $2.46 $2.55 $2.46 $2.51 166 403
Dec 15, 2023 $2.52 $2.56 $2.47 $2.48 194 277
Dec 14, 2023 $2.50 $2.53 $2.45 $2.50 447 531
Click to get the best stock tips daily for free!

About Relmada Therapeutics, Inc.

Relmada Therapeutics. Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that is in Phase 3 clinical trials for the adjunctive or monotherapy treatment of major depressive disorder ... RLMD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT